Mechanistically, the phosphorylated form of MARCKS was observed to associate with the transcription factor E2F1 to directly regulate the SKP2/P27 axis in promoting cell cycle progression and inhibiting apoptosis in drug-resistant MM cells. Here, CDKN1B is linked to Miyoshi myopathy.